110 related articles for article (PubMed ID: 12243772)
1. The 2-oxopyrrolidinacetamide piracetam reduces infarct brain volume induced by permanent middle cerebral artery occlusion in male rats.
Tortiglione A; Minale M; Pignataro G; Amoroso S; DiRenzo G; Annunziato L
Neuropharmacology; 2002 Sep; 43(3):427-33. PubMed ID: 12243772
[TBL] [Abstract][Full Text] [Related]
2. Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
Jiang N; Zhang RL; Baron BM; Chopp M
J Neurol Sci; 1996 Jun; 138(1-2):36-41. PubMed ID: 8791236
[TBL] [Abstract][Full Text] [Related]
3. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
[TBL] [Abstract][Full Text] [Related]
4. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion.
Sayeed I; Wali B; Stein DG
Restor Neurol Neurosci; 2007; 25(2):151-9. PubMed ID: 17726274
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability.
Zhang X; Zhang X; Wang C; Li Y; Dong L; Cui L; Wang L; Liu Z; Qiao H; Zhu C; Xing Y; Cao X; Ji Y; Zhao K
Brain Res; 2012 Jun; 1459():61-70. PubMed ID: 22560097
[TBL] [Abstract][Full Text] [Related]
6. Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion.
Cho J; Lee HK
Biol Pharm Bull; 2004 Oct; 27(10):1561-4. PubMed ID: 15467195
[TBL] [Abstract][Full Text] [Related]
7. Magnolol reduces glutamate-induced neuronal excitotoxicity and protects against permanent focal cerebral ischemia up to 4 hours.
Lee WT; Lin MH; Lee EJ; Hung YC; Tai SH; Chen HY; Chen TY; Wu TS
PLoS One; 2012; 7(7):e39952. PubMed ID: 22808077
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic Acetylcholine Receptor Alpha7 Subunit Mediates Vagus Nerve Stimulation-Induced Neuroprotection in Acute Permanent Cerebral Ischemia by a7nAchR/JAK2 Pathway.
Lu XX; Hong ZQ; Tan Z; Sui MH; Zhuang ZQ; Liu HH; Zheng XY; Yan TB; Geng DF; Jin DM
Med Sci Monit; 2017 Dec; 23():6072-6081. PubMed ID: 29274273
[TBL] [Abstract][Full Text] [Related]
9. The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion.
Cuomo O; Rispoli V; Leo A; Politi GB; Vinciguerra A; di Renzo G; Cataldi M
PLoS One; 2013; 8(11):e80852. PubMed ID: 24236205
[TBL] [Abstract][Full Text] [Related]
10. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
Sydserff SG; Borelli AR; Green AR; Cross AJ
Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
[TBL] [Abstract][Full Text] [Related]
11. A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
Kawasaki-Yatsugi S; Yatsugi S; Takahashi M; Toya T; Ichiki C; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
Brain Res; 1998 May; 793(1-2):39-46. PubMed ID: 9630503
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats.
Huh PW; Belayev L; Zhao W; Clemens JA; Panetta JA; Busto R; Ginsberg MD
Eur J Pharmacol; 2000 Feb; 389(1):79-88. PubMed ID: 10686299
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
14. Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression.
Liu Y; Zhang XJ; Yang CH; Fan HG
Brain Res; 2009 May; 1268():174-180. PubMed ID: 19285049
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia.
Hanon E; Klitgaard H
Seizure; 2001 Jun; 10(4):287-93. PubMed ID: 11466025
[TBL] [Abstract][Full Text] [Related]
16. AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
Yao H; Ibayashi S; Nakane H; Cai H; Uchimura H; Fujishima M
Brain Res; 1997 Apr; 753(1):80-5. PubMed ID: 9125434
[TBL] [Abstract][Full Text] [Related]
17. 6-Mercaptopurine exerts an immunomodulatory and neuroprotective effect on permanent focal cerebral occlusion in rats.
Chang CZ; Kwan AL; Howng SL
Acta Neurochir (Wien); 2010 Aug; 152(8):1383-90; discussion 1390. PubMed ID: 20464434
[TBL] [Abstract][Full Text] [Related]
18. Effects of pyruvate administration on infarct volume and neurological deficits following permanent focal cerebral ischemia in rats.
González-Falcón A; Candelario-Jalil E; García-Cabrera M; León OS
Brain Res; 2003 Nov; 990(1-2):1-7. PubMed ID: 14568323
[TBL] [Abstract][Full Text] [Related]
19. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies.
Liu Y; Belayev L; Zhao W; Busto R; Belayev A; Ginsberg MD
Eur J Pharmacol; 2001 Oct; 428(2):193-201. PubMed ID: 11675036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
